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INTRODUCTION: The primary method of leukemia acuic treatment is the 
program polychemotherapy (PCT), including ,-inthracycline antibiotics. The 
success of leukemia acute PCT depends on the adequate doses use and intervals of 
cytotoxic drugs assignment Liver injuries on the PCT background arc the limiting 
factor for the PCT in its entirety. The anthracycline antibiotics use is associated 
with the risk of the drug-induced liver injury (DILI) development 
AIMS A METHODS: The aim of study is to improve the effectiveness of 
treatment of the anthracycline-induced DILI through the development of new 
pharmacological complexes 
We examined 54 leukemia acute myeloid patients, who developed DILI in 
the PCT dynamics with doxorubicin during the remission induction and 
consolidation. All patients received ursodeoxycholic acid (UDCA) 20mg/kg 60 
days in combination with adcmcthioninc 1200 mg/day jet i.v. 10 days of the 
transition to I200mg/diy orally 50 days. 
RESULTS: The increased alkaline phosphatase (ALP) activity in 2,7 times 
(209±22.9 IU/1 vs 77.4± 10.8 111/1; p< 0.05k gamma-glutamyl tmnspeptidasc 
tGGT) - in 4.3 times (94.5± 10.39 IU/1 vs 21.9±2 42 IU/1; p<0.05), bilirubin - in 
4.8 times (58.1 ±8.71 IU I vs 12.1 ±1.33 IU/1; p<0.05). ALT - in 2.1 time 
(54.8±4.9 IU/1 vs 26.1 ±3.65 IU/1, p < 0.05). AST in 2.9 limes (57.1*6.86 IU/1 vs 
I9.7±2.36 IU/1; p<0.05) was found on the PCI background compared with healthy 
While the argynase blood activity decreased in 2.5 times and the concentration of 
the average weight molecules (AWM) increased in 1.9 times. 
After 30 days of treatment the ALT and AST activity decreased in 1.9 and 
2.1 times respectively; ALP, GGT, total bilirubin - in 1.4, 2 3. 2.8 times 
respectively. Ai the Зб* " бО* days of treatment the cytolytic and cholestatic 
syndromes parameters were normalized in 44 (81.5%) pts The correlation between 
the reduction of cholestasis clinical symptoms and ALP (рм4).76). GGT (Г-+0.85) 
activ ity was established. The argynase activity increased in 1.7 times on the 
background of decreased the AWM level in 1.5 times, reflecting the incrcnsed 
detoxication processes This allows to conduct PCT in full compliance wilh ihe 
cytostatics administration rcginicn. 
CONCLUSION: Thus, the combination of UDCA and adcmcthioninc in 
high doses is the optimal approach to treatmeni and prevention of DILI, induced by 
anthracyclines Disclosure of Interest: None Declared Gut 2012; 61 (Suppl Зі 
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